| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) | 11,416 | -11,006 | 3,729 | 15,653 |
| Provision for credit loss | NaN | 285 | 286 | 262 |
| (gain) loss on right of use assets | NaN | 0 | 0 | 0 |
| Gain on sale of property and equipment | NaN | 0 | 0 | 72 |
| Depreciation and amortization | 7,862 | 7,834 | 7,985 | 7,036 |
| Amortization-investment discount | 245 | 257 | 310 | 361 |
| Amortization-debt issuance costs | 507 | 440 | 440 | 441 |
| Equity-based compensation | 14,019 | 13,115 | 16,227 | 15,553 |
| Non-cash lease expense | 450 | 431 | 932 | -149 |
| Deferred premium revenue | NaN | NaN | 122 | -331 |
| Loss on extinguishment of debt | NaN | 0 | NaN | NaN |
| Accounts receivable | 24,471 | 33,655 | -62,808 | 69,104 |
| Prepaid expenses and other current assets | 47,256 | -27,267 | 27,993 | 12,533 |
| Other assets | 16 | 3 | -5 | 29 |
| Medical expenses payable | 181,398 | -54,227 | 73,642 | 58,420 |
| Accounts payable and accrued expenses | 287 | -816 | 2,626 | 3,346 |
| Accrued compensation | -14,725 | 733 | 5,264 | 10,662 |
| Lease liabilities | -544 | -511 | -1,013 | 85 |
| Net cash provided by operating activities | 128,682 | -50,375 | 144,556 | 29,130 |
| Purchase of investments | 10,598 | 20,439 | 10,193 | 17,096 |
| Sale of property and equipment | NaN | 0 | 0 | 75 |
| Maturities of investments | 18,540 | 18,305 | 18,005 | 17,295 |
| Sale of business | NaN | 0 | 0 | 1,065 |
| Acquisition of property and equipment | 7,364 | 5,029 | 5,497 | 8,003 |
| Contributions from noncontrolling interest holders | NaN | 0 | 0 | 0 |
| Net cash provided by (used in) investing activities | 578 | -7,163 | 2,315 | -6,664 |
| Proceeds from long-term debt | NaN | 0 | 0 | 0 |
| Repayment of long-term debt | NaN | 0 | NaN | NaN |
| Payment of employment taxes related to release of restricted stock | NaN | 0 | 0 | 0 |
| Debt issuance costs | 1,658 | 0 | 0 | 0 |
| Proceeds from stock option exercises | 2,173 | 15,296 | 948 | 1,616 |
| Net cash provided by financing activities | 515 | 15,296 | 948 | 1,616 |
| Net increase in cash | 129,775 | -42,242 | 147,819 | 24,082 |
| Cash, cash equivalents and restricted cash at beginning of period | 577,937 | 620,178 | 434,942 | NaN |
| Cash, cash equivalents and restricted cash at end of period | 707,712 | 577,937 | 620,178 | NaN |
Alignment Healthcare, Inc. (ALHC)
Alignment Healthcare, Inc. (ALHC)